Do you need more information on how to prepare and sign grants? Watch this Horizon 2020 webiner for successful proposal coordinators. [1] “IMI 2 JU is a public-private partnership that was created as a `joint enterprise` between the EU and the European Association of Pharmaceutical Industries and Associations (EFPIA). “Both are represented in the same way on the Board of Directors, the main decision-making body of IMI 2 JU. See europa.eu/european-union/about-eu/agencies/imi2_en. All project partners must sign a consortium agreement defining the rights and obligations of participants and addressing issues such as governance, liability and intellectual property rights. The agreement should be tailored to the needs of each project. A model developed by EFPIA shows what a consortium agreement might look like. Consortia can also use alternative models if they wish. Model consortium agreement that describes different types of access rights. Note that from IMI2 – Call 10 proposals must be submitted on the electronic bidding system of the financing and tender portal. . Please include your name, first name and address.
In order to facilitate the identification of the requested document, we recommend that you formulate your request as clearly and accurately as possible. Requests can be sent by email, fax or mail. As a general rule, the amendments apply only to new grant agreements. However, in some cases (for example. B if this has a benefit to recipient recipients), changes may be made retroactively to projects whose grant agreements are based on older versions of the standard grant agreement. This document explains in more detail and summarizes what is new in versions 3 and 4 compared to previous versions and which changes are retroactive. For more information on cost eligibility, please see the following documents: The IMI2 JU Model (MGA) grant agreement is updated from time to time in accordance with the broader MGA 2020 (H2020) grant agreement. You will always find the latest version of the IMI2 JU MGA via this link. Below are the links to certain versions and the IMI2 views to which they apply. Presentation of essential information for proposals, including clinical trials/studies/PDF Word studies Since this model is regularly updated, we recommend candidates always use this link to make sure they have the latest version. This page contains all documents relating to calls for proposals and projects launched under the IMI2 program.
It contains appeal texts, applicant documents, grant agreements and reports. The full list of decisions of the IMI2 Board of Directors is available on the Board of Directors page. Identifiable indirect taxes (including non-deductible VAT) paid by the beneficiary that are not reimbursed under national law are eligible.